Distalmotion has actually been given Afresh authorization by the United States Fda (FDA) to market the Dexter Surgical Robotic for grown-up inguinal rupture fixing. This substantial turning point marks an additional progression in Distalmotion’s goal to encourage robot surgical treatment quality by broadening accessibility and enhancing treatment with robot helped surgical treatment in the healthcare facility outpatient […].
发布者：Mark Allinson，转转请注明出处：https://robotalks.cn/us-fda-grants-authorization-for-distalmotion-surgical-robot-2/
